Aduro BioTech Inc (NASDAQ:ADRO) Under Investigation for Investors
Berkeley, CA based clinical-stage immunotherapy company Aduro BioTech Inc is under investigation over potential securities laws violations. The investigation was announced on behalf of investors inNASDAQ:ADRO shares in connection certain financial statements made by Aduro BioTech Inc.
View full press release